Tumor necrosis factor-alpha G-308 A polymorphism and risk of coronary heart disease and myocardial infarction: A case-control study and meta-analysis

Journal of Cardiovascular Disease Research

Volumn 3, Issue 2, 2012, Pages 84-90

  Chu, Hongxia ^a,b   Yang, Jun ^b   Mi, Shaohua ^b   Bhuyan, Soumitra Sudip ^c   Li, Jun ^b   Zhong, Lin ^b   Liu, Shaorong ^b   Tao, Zhigang ^b   Li, Jianping ^b   Chen, Hongying ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Coronary heart disease; meta analysis; myocardial infarction; polymorphism; tumor necrosis factor alpha

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; STATIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASIAN; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CHINESE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; DOMINANT GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RECESSIVE GENE; RISK FACTOR; SMOKING;

EID: 84860760014     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.95359     Document Type: Article

References (36)

1. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109:II2-10.
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Zhao SP, Ye HJ, Zhou HN, Nie S, Li QZ. Gemfibrozil reduces release of tumor necrosis factor-α¿ in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart. Clinica Chimica Acta 2003;332:61-7.
4. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 2000;100:263-9.
5. Ranjith N, Pegoraro RJ, Naidoo DP, Shanmugam R, Rom L. Genetic variants associated with insulin resistance and metabolic syndrome in young Asian Indians with myocardial infarction. Metab Syndr Relat Disord 2008;6:209-14.
6. Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafe M, Marchegiani F, et al. Tumor necrosis factor-alpha gene-308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis 2005;16:489-93.
7. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegard J, Wiman B, et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 2006;187:408-14.
8. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998;28:59-66.
9. Ghazouani L, Khalifa SB, Abboud N, Addad F, Khalfallah AB, Brahim N, et al. -308G>A and -1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease. Clin Chem Lab Med 2009;47:1247-51.
10. Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 2008;19:575-82.
11. Elahi MM, Gilmour A, Matata BM, Mastana SS. A variant of position -308 of the Tumour necrosis factor alpha gene promoter and the risk of coronary heart disease. Heart Lung Circ 2008;17:14-8.
12. Araujo F, Pereira AC, Mota GF, Latorre Mdo R, Krieger JE, Mansur AJ. The influence of tumor necrosis factor .308 and C-reactive protein G1059C gene variants on serum concentration of C-reactive protein: Evidence for an age-dependent association. Clinica Chimica Acta 2004;349:129-34.
13. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 2003;92:515-21.
14. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM, Benoit MO, et al. Use of the bioMerieux VIDASR troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clinica Chimica Acta 2008;390:72-5.
15. Shen GQ, Li L, Rao S, Abdullah KG, Ban JM, Lee BS, et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 2008;28:360-5.
16. Allen RD. Polymorphism of the human TNF-alpha promoter-random variation or functional diversity? Mol Immunol 1999;36:1017-27.
17. Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001;159:137-44.
18. Szalai C, Fust G, Duba J, Kramer J, Romics L, Prohaszka Z, et al. Association of polymorphisms and allelic combinations in the tumour necrosis factoralpha- complement MHC region with coronary artery disease. J Med Genet 2002;39:46-51.
19. Bernard V, Pillois X, Dubus I, Benchimol D, Labouyrie JP, Couffinhal T, et al. The -308 G/A tumor necrosis factor-alpha gene dimorphism: A risk factor for unstable angina. Clin Chem Lab Med 2003;41:511-6.
20. Tatenkulova SN, Mareev V, Zykov KA, Belenkov Iu N. The role of inflammatory factors in pathogenesis of ischemic heart disease. Kardiologiia 2009;49:4-8.
21. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, et al. Genotypes and haplotypes predisposing to myocardial infarction: A multilocus case-control study. Eur Heart J 2004;25:459-67.
22. Dedoussis GV, Panagiotakos DB, Vidra NV, Louizou E, Chrysohoou C, Germanos A, et al. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: The CARDIO2000-GENE Study. Genet Med 2005;7:411-6.
23. Giacconi R, Cipriano C, Muti E, Costarelli L, Malavolta M, Caruso C, et al. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients. Biogerontology 2006;7:347-56.
24. Sbarsi I, Falcone C, Boiocchi C, Campo I, Zorzetto M, De Silvestri A, et al. Inflammation and atherosclerosis: The role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol 2007;20:145-54.
25. Hou L, Huang J, Lu X, Wang L, Fan Z, Gu D. Polymorphisms of tumor necrosis factor alpha gene and coronary heart disease in a Chinese Han population: Interaction with cigarette smoking.Thromb Res 2009;123: 822-6.
26. Liu Y, Jin W, Lu L, Chen QJ, Shen WF. Association between single nucleotide polymorphism in the promoter of tumor necrosis factor-α¿ gene and coronary heart disease. J Diagn Concepts Pract 2009;5:506-9.
27. Li Y, Xu P, Chen H, Zhang PA, Huang CX. Association between tumor necrosis factor-α¿ G-308 A gene polymorphism and coronary heart disease: A case-control study. Chin J Geriatr 2003;9:568-9.
28. Shun SY, Zeng XQ, Qi AM, Fan WH, Zhang JC. Association of tumor necrosis factor-alpha gene polymorphisms in the promoter region with chronic periodontitis and coronary heart disease. J Clin Stomatol 2009;5:279-82.
29. Chen ZQ, Ma JF, Qiu FY, Shi SL, Chen H. Plasma levels of TNF-α¿, but not TNF-α¿ G-308 A gene polymorphism, is associated with coronary heart disease. Chin J Geriatr Cardiovasc Cerebrovasc Dis 2001;06:156-8.
30. Xiang PX, Li Y, Zhang PA, Chen H. Plasma TNF-α¿ level and TNF-α¿ gene polymorphism in patients with coronary heart disease: A case-control study. Lab Med 2004;5:434-7.
31. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, Ganesh S. Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 2009;27: 88-94.
32. Tulyakova G, Nasibullin T, Salmanov A, Avzaletdinova D, Khusnutdinova E, Zakirova A. Association of the -308 (G/A) polymorphism of tumor necrosis factor-α Á with myocardial infarction and sudden cardiac death. Balk J Med Genet 2004;8:31-5.
33. Wannamethee SG, Whincup PH, Shaper AG, Rumley A, Lennon L, Lowe GD. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost 2009;7:1605-11.
34. Sarwar N, Thompson AJ, Di Angelantonio E. Markers of inflammation and risk of coronary heart disease. Dis Markers 2009;26:217-25.
35. Kostner KM, Fahti RB, Case C, Hobson P, Tate J, Marwick TH. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease. Clinica Chimica Acta 2006;365:129-34.
36. Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, et al. Fibrinogen and coronary heart disease: test of causality by 'eMendelian randomization'f. Int J Epidemiol 2006 ;35:935-43.